Terragen’s Feedlot Trial Advances As Brazil Approves Probiotic Feed Additive
TGH: $0.014 +0.00% · MC: $12M
Terragen says its large-scale feedlot trial involving up to 10,600 cattle is progressing, with the animal trial expected to conclude in December and independent results due in March 2027; a separate supply agreement remains conditional, with first deliveries expected late this year. Brazil approved Terragen Probiotic as a feed additive, while cash and cash equivalents stood at approximately $6 million at quarter-end. The update also follows this week’s CEO departure: Joss West has taken over as interim CEO, and Daniel Pearce has agreed to remain CFO.

Comments